rewrite this content using a minimum of 1000 words and keep HTML tags
When the market pulls back, it becomes easier to see which stocks are built to last.
The names that tend to hold up best aren’t always the flashy ones, but established companies with resilient businesses and long records of rewarding shareholders.
And when I’m looking for income stocks, I tend to gravitate toward companies with a proven track record of long-term share price growth and consistent dividends. That led me to the Dividend Aristocrats, the elite group of S&P 500 companies that have raised their dividends for at least 25 straight years.
That’s why I filtered them to find the best-performing ones and checked which still have gas left in the tank.
Using Barchart’s Stock Screener, I selected the following filters to get my list:
5-Year Percent Change: I set it to at least 0.1% to show companies that are up over the last 5 years. Then, I will sort the results from highest to lowest.
Current Analyst Rating: 3.5-5. Stocks rated “Moderate” to “Strong Buy”, expecting a bullish potential by Wall Street.
Number of Analysts: 12 or more. Higher analyst coverage suggests a stronger rating consensus.
Dividend Investing Ideas: Dividend Aristocrats
I ran the screen and got 30 results. I will cover the three with the highest 5-year percent change.
Let’s kick off this list with the first Dividend Aristocrat.
Cardinal Health is a healthcare company with an outsized behind-the-scenes role in the current medical system. It distributes pharmaceuticals and medical products to hospitals, pharmacies, and laboratories, ensuring that supplies reach a wide range of healthcare providers.
The company is also expanding its biopharma supply chain capabilities to support the storage and delivery of sensitive therapies. As more specialty treatments reach the market, that role is becoming even more important.
Cardinal Health has increased its dividends for more than 25 consecutive years. Today, it pays a forward annual dividend of $2.04, yielding around 0.98%. While it may look modest, the stock gained 240% over the last five years.
Meanwhile, 16 analysts rate the stock a “Strong Buy”, with as much as 33% upside if the stock hits its target high of $275.
Story Continues
and include conclusion section that’s entertaining to read. do not include the title. Add a hyperlink to this website http://defi-daily.com and label it “DeFi Daily News” for more trending news articles like this
Source link
